Who we are
We are a team of clinical, med tech and engineering specialists committed to creating clinically effective, high performance single use flexible endoscopes on a global scale.
Using a novel and patented engineering approach, our range of single use endoscopes will deliver much needed change within endoscopy, addressing the huge demand for the service globally.
Our mission is to help endoscopists and their service providers improve their way of working, giving them greater flexibility, choice and control so they can increase capacity and ultimately save patients’ lives.
Progress to Date
Foundation of IQ Endoscopes
IQ Endoscopes started with founder Dr Patrick Ward-Booth in 2015. After 40 years’ experience in the field of endoscopy, he realised the huge impact a single use endoscope could have on the provision of a global service.
Innovation in design
In 2017, Dr Ward-Booth had a chance encounter with a materials expert from the automotive industry, Andrew Miller. Using a novel engineering approach to the design, an early-stage prototype was quickly developed with encouraging results. The design was granted a patent in July 2020.
Development of Technology Platform
The final stage prototype of our single use gastroscope is ready for regulatory approval.
A full range of GI endoscopes will then follow between 2024 and 2025.
Secured £5.2m Series B funding
The funding will help to support the development of IQ Endoscopes’ ground-breaking medical devices.
Meet Our Team
Dr Patrick Ward-Booth
Dr Patrick Ward-Booth is a clinical endoscopist with 40 years’ experience in industry and is an expert in service provision and clinical acceptance requirements. He founded IQ Endoscopes in 2015 to transform how endoscopy services are delivered by eliminating many of the challenges doctors face with current endoscopes. Patrick introduced the routine use of transnasal endoscopy into the UK and was the regional lead for a national endoscopy quality improvement programme before going on to start a community-based endoscopy business, which was sold to In Health after reaching 10,000 procedures.
Co-Founder and Chief Technology Officer
Andrew is an engineer with over 30 years’ experience. Until 2017 Andrew was CTO of Thatcham Research, directing technical strategy on behalf of the UK Motor Insurers to reduce claims costs and to ensure accurate risk pricing for new vehicles entering the UK market. Andrew has worked closely with vehicle manufacturers, UK and International governments and the international insurance industry. Until 2017 Andrew was President and Chairman of the European consumer safety organisation Euro NCAP. For many years he was a Steering Committee member of the International Research Council for Automotive Repairs. Andrew is a founding Director of IQ Endoscopes and directs the company’s technical and product development strategy.
Chief Executive Officer
With more than 20 years’ experience of commercial and executive leadership across medical device and medical technology companies, Matt has been hugely successful in launching disruptive technologies on a global scale throughout his career. Having previously held senior leadership positions within Proximie, Molnlycke Healthcare and CR Bard, he joined IQ Endoscopes in October 2020 bringing his extensive medical device, product development, regulation and commercialisation knowledge to the team.
Chief Operations Officer
Dr Felicity Sartain is responsible for leading the supply chain and product manufacture activities, designing and implementing corporate strategy, and monitoring the efficiencies of operational processes. She has a multi-disciplinary background established over 20 years including leadership, commercial and research in the healthcare, life science and nanotechnology sectors. She holds a PhD in Biotechnology from the University of Cambridge and an MSc in Chemistry from the University of York and was a co-inventor of technologies at a novel biosensor company – Smart Holograms. Felicity co-founded and was the Chief Operating Officer of Closed Loop Medicine Ltd, a company developing therapeutic combination products. She is also the Founder & Director at Profiscio Ltd, a consultancy business to support the translation and manage the development of scientific innovation and is a Non-Executive Director at Nanosynth Group Plc.
Global Strategic Marketing Director
Chris has worked in the medical industry for over 20 years across pharmaceuticals, diagnostics and medical devices. He has held multiple positions in both Sales and Marketing covering multiple geographies and leading different teams. His passion for the industry stems from enabling the adoption of innovative technologies that improve patients’ outcomes, this has been a constant throughout his career.
Chief Financial Officer (Part-Time)
Tom is a qualified Chartered Accountant having trained at Deloitte. He has over 14 years’ experience in industry in high tech global growth companies from large-listed businesses to start up SME’s. His passion is helping businesses with a strong purpose and social responsibility both in what they want to deliver and how they go about doing it. He also holds an FD role at Creo Medical and sits on the board as a NED of Marine Power Systems.
Head of Quality, Regulatory & Compliance
Chris Jenkins has approximately 14 years’ experience in Medical Device, Pharmaceutical and Combination Devices, having held positions in Manufacturing, R&D, Regulatory and Compliance. Chris was one of the first to join the company in May 2021, to drive the company’s regulatory strategy and instil quality into the products and processes, with a strong focus on integrating continuous improvement.
ARE YOU READY?
Ready to significantly reduce your fixed costs and move decision-making from fixed to operational costs.